XDx, Inc. Announces Presentations at Upcoming 2013 International Society for Heart and Lung Transplantation Meeting
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive tests to monitor immune status in transplant recipients and autoimmune diseases, today announced clinical investigators will present results from six AlloMap® studies at the 33rd Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT), taking place April 24-27, 2013 at the Palais des Congres in Montreal, Canada.
Help employers find you! Check out all the jobs and post your resume.
XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive tests to monitor immune status in transplant recipients and autoimmune diseases, today announced clinical investigators will present results from six AlloMap® studies at the 33rd Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT), taking place April 24-27, 2013 at the Palais des Congres in Montreal, Canada.
Help employers find you! Check out all the jobs and post your resume.